We are live on ! Find out more
OA

Oak Associates Portfolio holdings

AUM $1.49B
1-Year Est. Return 34.25%
This Fund
S&P 500
This Quarter Est. Return
+15.35%
1 Year Est. Return
+34.25%
3 Year Est. Return
+111.6%
5 Year Est. Return
+123.41%
10 Year Est. Return
+571.62%
AUM
$1.65B
AUM Growth
+$158M
Cap. Flow
-$37.9M
Cap. Flow %
-2.29%
Top 10 Hldgs %
48.4%
Holding
142
New
11
Increased
37
Reduced
35
Closed
5

Top Buys

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$15.6M
2
CRM icon
Salesforce
CRM
+$3.28M
3
DKNG icon
DraftKings
DKNG
+$3.2M
4
ZBH icon
Zimmer Biomet
ZBH
+$2.24M
5
META icon
Meta Platforms (Facebook)
META
+$2.11M

Top Sells

Rank Stock Value
1
GILD icon
Gilead Sciences
GILD
+$10.9M
2
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$10M
3
CI icon
Cigna
CI
+$9.59M
4
IBM icon
IBM
IBM
+$7.63M
5
NTAP icon
NetApp
NTAP
+$5.21M

Sector Composition

Rank Sector Weight
1 Technology 38.78%
2 Communication Services 14.27%
3 Healthcare 14.18%
4 Consumer Discretionary 14.17%
5 Financials 9.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ALXN
76
DELISTED
Alexion Pharmaceuticals
ALXN
$2.09M 0.13%
13,390
LRCX icon
77
Lam Research
LRCX
$372B
$2.02M 0.12%
42,850
NVO
78
Novo Nordisk
NVO
$228B
$2.02M 0.12%
57,930
-6,990
-11% -$242K
MRK icon
79
Merck
MRK
$321B
$1.94M 0.12%
24,880
EXEL icon
80
Exelixis
EXEL
$14.1B
$1.93M 0.12%
+96,090
New +$2.01M
SNY icon
81
Sanofi
SNY
$103B
$1.92M 0.12%
39,570
-3,810
-9% -$188K
PRFT
82
DELISTED
Perficient Inc
PRFT
$1.9M 0.11%
39,890
+2,145
+6% +$97.3K
FFIV icon
83
F5
FFIV
$22.1B
$1.85M 0.11%
10,525
PANW icon
84
Palo Alto Networks
PANW
$265B
$1.81M 0.11%
30,600
SIMO icon
85
Silicon Motion
SIMO
$8.65B
$1.71M 0.1%
35,475
+3,570
+11% +$146K
CAH icon
86
Cardinal Health
CAH
$53.2B
$1.69M 0.1%
31,479
VRTX icon
87
Vertex Pharmaceuticals
VRTX
$122B
$1.67M 0.1%
7,050
-12,090
-63% -$2.77M
FTNT icon
88
Fortinet
FTNT
$113B
$1.65M 0.1%
55,450
REGN icon
89
Regeneron Pharmaceuticals
REGN
$77.4B
$1.54M 0.09%
3,195
+195
+7% +$105K
VRNT
90
DELISTED
Verint Systems
VRNT
$1.54M 0.09%
44,933
PCTY icon
91
Paylocity
PCTY
$7.32B
$1.49M 0.09%
7,220
-2,000
-22% -$385K
MA icon
92
Mastercard
MA
$510B
$1.48M 0.09%
4,139
JNJ icon
93
Johnson & Johnson
JNJ
$617B
$1.44M 0.09%
9,143
SAIC icon
94
Saic
SAIC
$4.89B
$1.01M 0.06%
10,665
+5,000
+88% +$440K
EB
95
DELISTED
Eventbrite
EB
$969K 0.06%
53,558
+8,500
+19% +$119K
TFC icon
96
Truist Financial
TFC
$63.5B
$890K 0.05%
18,568
-3,735
-17% -$169K
TRV icon
97
Travelers Companies
TRV
$78.4B
$838K 0.05%
5,968
-15,320
-72% -$1.97M
VTRS icon
98
Viatris
VTRS
$20.7B
$793K 0.05%
42,340
+24,220
+134% +$395K
WK icon
99
Workiva
WK
$3.29B
$780K 0.05%
8,510
+2,430
+40% +$171K
CVSA
100
Covista Inc
CVSA
$4.3B
$702K 0.04%
20,665
+3,275
+19% +$93.4K

Similar funds

Oak Associates's Q4 2020 Portfolio in Review

As of Q4 2020, Oak Associates held 142 positions worth $1.65B, up 11% from $1.5B the previous quarter. Its ten largest holdings account for 48% of the portfolio.

Oak Associates's Q4 2020 filing shows 11 new, 37 increased, 35 reduced and 5 closed positions. Its largest new stake was Exelixis: 96,090 shares worth $1.93M. The largest sale was Gilead Sciences, an estimated $10.9M.

By sector, the portfolio is most concentrated in Technology at 39% of assets, up from 38% a quarter earlier, followed by Communication Services and Healthcare.

  • Oak Associates's largest Q4 2020 buy was Exelixis: 96,090 shares worth $1.93M.
  • Oak Associates added most to JPMorgan Chase in Q4 2020, an estimated $15.6M increase.
  • Oak Associates's biggest Q4 2020 reduction was Gilead Sciences, cutting an estimated $10.9M.
  • Oak Associates fully exited Juniper Networks in Q4 2020, selling an estimated $1.17M.
  • Oak Associates's ten largest holdings make up 48% of its $1.65B portfolio in Q4 2020.
  • Oak Associates opened 11 new positions and closed 5 in Q4 2020.
  • Oak Associates's portfolio value rose 11% quarter-over-quarter to $1.65B.

Based on Oak Associates's 13F filing for Q4 2020, filed 12 Feb 2021.